Form 4: Harmony Biosciences CFO Sandip Kapadia Reports Stock Transactions
SEC Form 4
Sandip Kapadia, CFO of Harmony Biosciences Holdings, Inc., reports the vesting and subsequent tax withholding of restricted stock units.
Summary
- On September 30, 2024, Sandip Kapadia, the CFO of Harmony Biosciences Holdings, Inc., reported transactions involving the company's common stock.
- Specifically, 60,000 shares were acquired upon the vesting of restricted stock units at a price of $0.
- Simultaneously, 32,052 shares were withheld by the issuer to cover income tax obligations at a price of $40, resulting in a net decrease of 27,948 shares held directly.
- Following these transactions, Kapadia directly owns 27,948 shares of Harmony Biosciences Holdings, Inc.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing reflecting standard compensation practices; it doesn't inherently indicate positive or negative sentiment.
Future Outlook
The remaining restricted stock units will vest in two tranches: 30% on September 30, 2025, and 30% on September 30, 2026.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company executives. It is a standard practice for publicly traded companies.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects standard executive compensation and does not significantly alter the company's financial position.
Key Dates
| Date | Description |
|---|---|
| 10/04/2023 | Date the restricted stock units were previously granted. |
| 09/30/2024 | Date of the reported stock transactions, including vesting of restricted stock units and tax withholding. |
| 09/30/2024 | 40% of the underlying shares vested. |
| 09/30/2025 | 30% of the underlying shares shall vest. |
| 09/30/2026 | 30% of the underlying shares shall vest. |
| 10/02/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.